Biography

Giampiero is a Professor at Kingston University and a Fellow of the Royal Society of Public Health (RSPH), the Royal Society of Medicine (RSM) and the European Cancer Organisation (ECCO).
Before joining Academia, he had increasing financial and strategic responsibilities in the Life Science industry. As a corporate finance practitioner, Giampiero gained a significant experience in the valuation of intangible assets and M&A investments.
Reflecting on his corporate experience, he dedicated his academic research to defining the boundaries of uncertainty and, consequently, to estimate its "value". His most relevant theoretical contribution to the field has been the fuzzy pay-off, the first "possibilistic" rather than "deterministic" capital asset pricing model. The pay-off model found its application in a broad range of investment decisions, from Corporate Finance (Real Options, IPO pricing) to Investments (valuation of R&D and infrastructure projects).
Over the last decade, Giampiero stretched the generalizability of the uncertainty principle to the valuation of the most challenging asset, human life. The early contributions of our research Public Health policy decisions have been highly encouraging.
Our seminal study published in Vaccine, the most authoritative scientific journal in public health immunization, demonstrated that previous cost-effectiveness evidence against the inclusion of boys in the HPV vaccination ignored the value of uncertainty. Consequently, by challenging the boundaries of herd immunity, the research raised the concern that public healthcare policy might have been built upon incomplete economic models. The study outcomes contributed to changing the Public Health England's opinion in support of a gender-neutral immunization programme. Today, over 2.5 million boys are vaccinated against HPV in the European Community (EEA, including the U.K.).
More recently, our study published in 2021 in the Oxford Journal of Public Health was the first to quantify the relative mortality risk following COVID-19 infection in frail, elderly individuals resident in nursing and retirement homes (RSA). By raising awareness of this critical public health risk, the study contributed to reducing the excess mortality in care homes expected during the second wave of the pandemic.